Pulmatrix, Inc.
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized**.**
| PULMATRIX, INC. | |||
| Date: | February 26, 2026 | By: | /s/ Peter Ludlum |
|---|---|---|---|
| Peter Ludlum | |||
| Interim Chief Executive Officer and Interim Chief Financial Officer (Principal Executive, Financial and Accounting Officer) | |||
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each of the undersigned directors of Pulmatrix, Inc., a Delaware corporation, hereby constitutes and appoints Peter Ludlum as his true and lawful attorney-in-fact and agent, with full power of substitution and revocation, for and in his or her name, place and stead, in any and all capacities, to sign the Annual Report on Form 10-K of Pulmatrix, Inc. for the year ended December 31, 2025, and any and all amendments and supplements thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto each said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary as fully as to all intents and purposes as he or she might or could do in person, and hereby ratifying and confirming all that each said attorney-in-fact and agent or his or her substitute(s) may lawfully do or cause to be done by virtue hereof.
| Signature | Title | Date |
|---|---|---|
| /s/ Peter Ludlum | Interim Chief Executive Officer and Interim Chief Financial Officer | February 26, 2026 |
| Peter Ludlum | ||
| (Principal Executive, Financial and Accounting Officer) | ||
| /s/ Michael J. Higgins | Chairman of the Board of Directors | February 26, 2026 |
| Michael J. Higgins | ||
| /s/ Richard Batycky, Ph.D. | Director | February 26, 2026 |
| Richard Batycky, Ph.D. | ||
| /s/ Todd Bazemore | Director | February 26, 2026 |
| Todd Bazemore | ||
| /s/ Christopher Cabell, M.D. | Director | February 26, 2026 |
| Christopher Cabell, M.D. | ||
| /s/ Anand Varadan | Director | February 26, 2026 |
| Anand Varadan | ||
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| Page | |
| Report of Independent Registered Public Accounting Firm – CBIZ CPAs P.C. (PCAOB ID: 199) | F-2 |
|---|---|
| Report of Independent Registered Public Accounting Firm – Marcum LLP (PCAOB ID: 688) | F-3 |
| Consolidated Balance Sheets as of December 31, 2025 and 2024 | F-4 |
| Consolidated Statements of Operations for the Years Ended December 31, 2025 and 2024 | F-5 |
| Consolidated Statements of Stockholders’ Equity for the Years Ended December 31, 2025 and 2024 | F-6 |
| Consolidated Statements of Cash Flows for the Years Ended December 31, 2025 and 2024 | F-7 |
| Notes to Consolidated Financial Statements | F-8 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.